Top compounds associated with response to OCLN


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.2
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC 0.06 0.2
mRNA Teniposide CTRPv2 pan-cancer AAC -0.067 0.2
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.054 0.2
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.2
mRNA thapsigargin gCSI pan-cancer AAC -0.11 0.2
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.061 0.2
mRNA cimetidine CTRPv2 pan-cancer AAC -0.11 0.2
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.06 0.2
mRNA R428 CTRPv2 pan-cancer AAC 0.072 0.2
Download CSV